April 17, 2024
The average deal size was $20.6 million; 40% of Q1's funding total went to AI-enabled companies ($1.1B across 45 deals), rising from 33% of 2023 digital health funding
April 17, 2024
Using VR provided more nonpharmacologic pain relief than active control and this benefit sustained long after the conclusion of the intervention
April 15, 2024
The grant from the National Multiple Sclerosis Society will support ADSCC's ongoing clinical trials, particularly the Extracorporeal Photopheresis (ECP) for Optimal Management of Multiple Sclerosis study, which started in 2022
April 13, 2024
The new feature, called Foggy, within h2o therapeutics' Parky app for Apple Watch is available by prescription for people with Parkinson's disease
April 11, 2024
New Bayer innovation platform will help organizations build AI-powered apps that assist radiologists, reducing burnout and supporting more efficient diagnoses
April 10, 2024
Created by experts at Nottingham Trent University, diseased model hearts and lungs can breathe and bleed like real organs
April 10, 2024
The tool may offer a prescription safety net and reduce the 237 million medication errors made each year in England
April 10, 2024
UPMC researchers published a study demonstrating the efficacy of Pip Care, a surgical app and healthcare coaching platform
April 10, 2024
The My Mental Health Journey registry is now enrolling adults experiencing symptoms of depression in the U.S. to advance research in mental health and support more precise treatment options
April 10, 2024
Tens of thousands of people with type 1 diabetes in England are to be offered a new technology to help manage the condition
💡Did you know?
You can take your DHArab experience to the next level with our Premium Membership.👉 Click to learn more
🛠️Featured tool
Easy-Peasy
An all-in-one AI tool offering the ability to build no-code AI Bots, create articles & social media posts, convert text into natural speech in 40+ languages, create and edit images, generate videos, and more.
👉 Click here to learn more
